Romanian Neurosurgery | Volume XXXI | Number 2 | 2017 | April-June
Article
Intracranial actinomycosis: case report and
review of literature
Alfonso Pacheco-Hernandez, Jorque Aquino-Matus, Willem Guillermo Calderon-Miranda, Jean Carlos Pinto-Angarita,
Ronsangela Ramirez-Barranco, Katherine Gomez-Barragan, Ernesto Jose Rocha-Reyes, Marco Antonio Blancas-Rivera,
Zyanya Patricia Carbajal Menes, Paulo Cesar Puac Polanco, Guru Dutta Satyarthee, Luis Rafael Moscote-Salazar
COLOMBIA, MEXICO, USA, INDIA
DOI: 10.1515/romneu-2017-0042
248 | Pacheco-Hernandez et al - Intracranial actinomycosis
DOI: 10.1515/romneu-2017-0042
Intracranial actinomycosis: case report and review of
literature
Alfonso Pacheco-Hernandez1, Jorque Aquino-Matus2, Willem
Guillermo Calderon-Miranda2, Jean Carlos Pinto-Angarita1,
Ronsangela Ramirez-Barranco1, Katherine Gomez-Barragan1,
Ernesto Jose Rocha-Reyes1, Marco Antonio Blancas-Rivera2, Zyanya
Patricia Carbajal Menes3, Paulo Cesar Puac Polanco4, Guru Dutta
Satyarthee5, Luis Rafael Moscote-Salazar1
1
Universidad de Cartagena, Cartagena de Indias, COLOMBIA
Universidad Nacional Autonoma de Mexico, Mexico City, MEXICO
3
Hospital General Dr. Manuel Gea González; National Autonomous University of Mexico School
of Medicine, Mexico City, MEXICO
4
Neuroradiology section, Department of Radiology, University of North Carolina School of
Medicine, USA
5
Department of Neurosurgery, Neurosciences Centre, All India Institute of Medical Sciences, New
Delhi, INDIA
2
Abstract: Actinomycosis infection is a slow progressing disease, in which involvment of
the central nervous system by Actinomyces israelii is uncommon (less than 5%). Clinical
picture is non-specific and is often misdiagnosed with neoplasia; some clinical clues my
arise suspicion. The case of a 59 year-old female is reported who presented headache and
focal neurologic signs and in whom a out-of the hospital diagnosis of a neuroepitelial
dysembryoplastic tumor was made; nonetheless after careful interview and physical
exploration, a spectroscopy magnetic resonance of the brain and hystopathological
description of the lesion was made and yielded the definitive diagnosis of intracranial
actinomyces infection. Treatment and progression were uneventful.
Key words: actinomycosis, intracraneal, Infection, brain, abscess, tumor
Introduction
Actinomycosis is a slow progression
infection
caused
by
filamentous
microaerophilic anaerobic Gram positive
bacteria from the family Actinomycetaceae
(1). It has been supposed to be similar to fungi
for the similarity in ramification and the
formation of a mycelial net; nonetheless the
presenece of muraminic acid in the cellular
wall and the absence of a nuclei attached to the
Romanian Neurosurgery (2017) XXXI 2: 248 - 252 | 249
cellular membrane, clearly differentiate them
into prokaryotic bacteria (schizomycetes)
closely related to mycobacteria. (2). The most
common species from the Actinomycetes
gender are: Nocardia, Streptomyces and
Actinomyces; being A. israelii the common
among them. (3)
Actinomycosis is a relatively rare infection
that occurs 1 in 300,000 persons per year. Men
are affected three times more than women (3).
The clinical picture and radiologic findings are
unspecific, and are similar to any pyogenic
abscess (4).
Actinomycosis infection to the Central
Nervous System is generally secondary to
hematogenous disemmination from the
primary infection in the lung, abdomen, pelvis
or by continuity in a cervical, oral or facial
infection, since it is closely related to
mycobacteria
in
the
mouth
and
gastrointestinal tract (5-9). Since infection to
the CNS is not common, it may be
misdiagnosed with a cerebral neoplasia (1).
Therefore, we report the case of a 59 years-old
female with CSN actinomycosis in the
National Institute of High Technology at
Monteria, Colombia.
Case presentation
A 59 years-old female with past medical
history of Hypertension under treatment with
Losartan, Type 2 Diabetes Mellitus under
treatment with homeopathy, and previously
heavy smoker who had been admitted in the
past 6 months with holocraneal headache
resistant to analgesics and associated with
nausea, vomiting, and loss of vision in the left
eye, temporospatial disorientation and blurred
speech. She was admitted on May 2016 with an
occupying lesion in the brain and a
Gadolinium-enhanced Magnetic Resonance
Imaging (MRI) suggested a dysembryonic
neuroepithelial tumor (DNET). (Figures 1 A
and B). A Spectroscopy MRI reported a lowsignal poorly defined lesion in T1 sequence
and high-signal in T2 sequence compromising
the amygdala, hippocampus, uncus, left
thalamus in its posterior portion and
extending to the left occipitotemporal and
inferior temporal gyrus. Additionaly, some
contrast enhanced nodular foci were seen.
Spectroscopy study reported high levels of
choline, creatine and low levels of Nacetylaspartate. She underwent a craniectomy
with resection of the 100% of the lesion by a
left partial temporal lobectomy. Postoperative
head CT scan reported a hypodensity in the
surgical bed with a small left pericapsular
hematoma and no mass effect. She persisted
disoriented but with no neurological deficit.
She was discharged at the 6th day after surgery.
Nonetheless, she was readmitted and in the ER
she was found with a CGS 9 points (E2 V2
M5), reactive pupils, right hemiparesis and
ipsilateral pyramidal syndrome. Brain CT scan
was unremarkable and histopathological
studies from previous surgery resection were
obtained and reported reactive inflammatory
changes in glia, mononuclear infiltrate in the
perivascular space, mononuclear infiltrate and
neuropil edema with presence of filamentous
structures
compatible
with
chronic
encephalitis corresponding to cerebral
actynoimicosis. Laboratory workup reported
leukocytes in 15.8x10^9/L and sodium in 125
mEq/L, which explained neurological deficit
that recovered after sodium IV reposition over
the next 48 hours. Antibiotic therapy was
250 | Pacheco-Hernandez et al - Intracranial actinomycosis
initiated with Penicillin G 2 million IV QID for
10 days followed by Penicillin VK 2 grams
PO/day for 6 months. Evolution was
uneventful but persisted with temporo-spatial
disorientation.
A
B
Figures 1 A and B - Brain IRM showing a low-signal
poorly defined lesion in T1 sequence and high-signal
in T2 sequence compromising the amygdala,
hippocampus, uncus, left thalamus in its posterior
portion and extending to the left occipitotemporal
and inferior temporal gyrus
Discussion
Actinomycosis is an infrequent and slow
progression infection which originates
partially from the normal buccal flora. A
crucial step in the development of the infection
is the loss of the mucosal barrier. (10)
Actinomycosis usually produces acute
purulent infections which confluent foci may
form cavities and cause chronic abscesses.
Metastasis seldom occurs and it is favored by
hematogenous dissemination. (11) Sites of
infection are in the head and neck (50%),
abdomen (20%), thorax (15%), pelvis, heart
and brain (15%). Central nervous system
infection is rare and it occurs in less than 5%
of cases. Pathogenesis is believed to occur as a
direct invasion from head and neck tissues, as
well as lower mandible, ears and paranasal
sinus, through the fascia and extending
through the skull base and meninges. Other
mechanisms postulated are the perineural
extension through the intervertebral spaces
and hematogenous dissemination. (3)
In cerebral actinomycosis, common
clinical features are headache and focal
neurological signs (12), and symptoms may be
present for a long time and fever may not
occur. Infection present as brain abscess
(67%), meningitis and meningoencephalitis
(13%), actinomycoma (7%), epidural or
subdural space infection (7%) (13).
A distinctive characteristic of cerebral
actinomycosis is a chronic indolent phase with
presence of solitary or multiple lesions.
Therefore, diagnosis requires a high clinical
suspicion, relying on the chronicity, slow
progression, characteristic features on brain
Romanian Neurosurgery (2017) XXXI 2: 248 - 252 | 251
imaging and refractory/recurrent natural
history. (11) Nonetheless, actinomyces are
underestimated bacteria as cause of infections,
and therefore are underdiagnosed. (11)
CNS actinomycosis must be suspected in
patients
with
previous
history
of
actinomycosis in other sites and presenting
with long duration of neurologic symptoms
with or without fever. Common risk factors
include HIV infection, AIDS, dental
procedures, history of head, gastrointestinal,
otorhinolaryngologic
surgery,
cyanotic
congenital heart disease and use of
intrauterine devices. (6, 13, 14)
Brain imaging is not helpful into
differentiate among other infectious and noninfectious diseases; CT scan or MRI may
report a irregular o nodular ring-shaped thick
wall lesion. (15) CT scan identifies cerebral
and cerebellum abscesses which are generally
solitary but may be multiple (in combination
with a granulomas) and present homogeneous
enhancement with a thick wall and
perilesional edema (16). MRI identifies better
lesion in the subdural space, cavernous sinus
and inner ear canal in patients with acute
purulent meningitis. Spectroscopy mar reveal
elevation in amino acids, acetate and
succinate. (17)
There is no serologic or skin test available.
Microbiologic identification of actinomyces
may take up to 3 weeks and has low in
sensibility. (18) In cases where culture is
positive, the most commonly found associated
with CNS infection is A. israelii; other species
found are A. naeslundii which may cause
subdural empyema and A. viscosus (10-21).
Therefore, diagnosis is usually made with
histopathological studies.
Actinomyces is identified by an outer zone
of granulation tissue, a purulent core with
azurophilic granules measuring 1-2 mm
(associated with a calcium phosphate
compounds), and fibrotic walls surrounding a
neutrophilic infiltrate. (17). Differential
diagnosis includes tuberculosis, fungi,
nocardiosis, other germs and neoplasia. (11)
Successful treatment requires drainage of
the primary abscess followed by systemic
antibiotics. Surgical debridement should be
aggressive with complete resection of the
capsule. (11) Penicillin remains the drug of
choice but at high doses and during a long
course (6 to 12 months). (22). Penicilin G (1824 mIU/day divided in 6 doses) for 4 to 6
weeks is followed by Penicillin VK (1-2
grams/day divided in 4 doses); alternatively,
Amoxicilin (1.5 grams/day divided in 3 doses
for 6 to 12 months) may be used.
Individualized treatment is always mandatory.
Other antibiotics that have showed efficacy but
with limited experience are Imipenen,
Ceftriaxone, and Ciprofloxacin. Antibiotics as
Metronidazole,
ThrimetoprimSulfametoxazole, Ceftazidime, Oxacilin,
amynoglucosides and fluoroquinolones are
not effective but may be used in polymicrobial
infections according to antibiotic sensitivity
tests. (22)
A long course of antibiotic therapy must be
completed to assure eradication of infection.
Treatment must be individualized and if
extended beyond clinical remission, risk of
recurrence is minimized. CT and MRI should
be used to monitor treatment response. (22)
252 | Pacheco-Hernandez et al - Intracranial actinomycosis
References
1. Bello Y. E, Ojeda P, Mosquera O. A, Martínez F, Lozano
A. J. Actinomicosis del sistema nervioso central:
presentación de caso. Rev Colomb Radiol. 2013; 24(4):
3827-31.
2. Tsai MS, Tarn JJ, Liu KS, Chou YL, Shen CL. Multiple
actinomyces brain abscesses: case report. J Clin Neurosci
Off J Neurosurg Soc Australas. 2001 Mar;8(2):183–6.
3. Van Dellen JR. Actinomycosis: an ancient disease
difficult to diagnose. World Neurosurg. 2010 Sep;74(23):263–4.
4. Riesgo P, Orozco M, Piquer J, Cortés F, Botella C,
Navarro J, Cabanes J. Absceso cerebral actinornicótico:
caso clínico. Neurocirugía 1996; 7: 230-234.
5. Ewald C, Kuhn S, Kalff R: Pyogenic infections of the
central nervous system secondary to dental affections. A
report of six cases. Neurosurg Rev 29:163- 167, 2006.
6. Nithyanandam S, D’Souza O, Rao SS, Battu RR, George
S: Rhinoorbitocerebral actinomycosis.Ophthal Plast
Reconstr Surg 17:134-136, 2001.
7. Salvati M, Ciappetta P, Raco A, Artico M, Artizzu S.
Primary intracranial actinomycosis. Report of a case and
review of the literature. Zentralblatt Für Neurochir.
1991;52(2):95–8.
8. Corbin D, Solaro L, Flint G, Williams AC:
Actinomycotic brain abscess following abdominal
suppuration. J Neurol Neurosurg Psychiatry 50:17051706, 1987.
9. Trutnovsky G, Tamussino K, Reich O: Short-term
antibiotic treatment of pelvic actinomycosis. Int J
Gynaecol Obstet 101:203-204, 2008.
10. Roth J, Ram Z. Intracranial infections caused by
Actinomyces species. World Neurosurg. 2010 Sep;74(23):261–2.
11. Akhaddar A, Elouennass M, Baallal H, Boucetta M.
Focal intracranial infections due to Actinomyces species
in immunocompetent patients: diagnostic and
therapeutic challenges. World Neurosurg. 2010 Sep;74(23):346–50.
12. Akhaddar A, Elmostarchid B, Boucetta M. Primary
subdural empyema after spontaneous vaginal delivery.
Surg Infect. 2009 Aug;10(4):363–4.
13. Smego RA, Jr: Actinomycosis of the central nervous
system. Rev Infect Dis 9:855-865, 1987.
14. Olah E, Berger C, Boltshauser E, Nadal D. Cerebral
actinomycosis before adolescence. Neuropediatrics. 2004
Aug;35(4):239–41.
15. Soto-Hernández JL, Morales VA, Lara Giron JC,
Balderrama Bañares J: Cranial epidural empyema with
osteomyelitis caused by Actinomyces, CT, and MRI
appearance. Clin Imaging 23:209-214, 1999.
16. Adeyemi OA, Gottardi-Littell N, Muro K, Kane K,
Flaherty JP. Multiple brain abscesses due to Actinomyces
species. Clin Neurol Neurosurg. 2008 Sep;110(8):847–9.
17. Wang S, Wolf RL, Woo JH, Wang J, O’Rourke DM,
Roy S, et al. Actinomycotic brain infection: registered
diffusion, perfusion MR imaging and MR spectroscopy.
Neuroradiology. 2006 May;48(5):346–50.
18. Desai A, Lollis SS, Missios S, Radwan T, Zuaro DE,
Schwarzman JD, Duhaime AC: How long should
cerebrospinal fluid cultures be held to detect shunt
infections?. Clinical article. J Neurosurg Pediatr 4:184189, 2009.
19. Bebrova E, Lochmann O, Tichy M, Nyc O:
Actinomyces viscosus in subdural empyema. Epidemiol
Mikrobiol Imunol 43:21-22, 1994.
20. Jamjoom AB, Jamjoom ZAB, Al-Hedaithy SS:
Actinomycotic brain abscess successfully treated by burr
hole aspiration and short course antimicrobial therapy. Br
J Neurosurg 8:545-550, 1994.
21. Hirai T, Nunoya T, Azuma R: Actinomycosis of the
brain and temporal bone in a goat. J Vet Med Sci 69:641643, 2007.
22. Brook I. Actinomycosis: diagnosis and management.
South Med J. 2008 Oct;101(10):1019–23.